Financial Review on Healthcare Stocks Teva Pharmaceutical

Financial Review on Healthcare Stocks Teva Pharmaceutical Industries
Ltd. and Allergan Inc. -- Drug Manufacturers Focusing on Expansion
and Litigation 
NEW DELHI, INDIA -- (Marketwire) -- 11/01/12 --  The drug
manufacturers -- other industry, which features companies such as
Teva Pharmaceutical Industries Limited and Allergan Inc., has been
operating under complex conditions as of late. Patent expirations
continue to negatively impact financials while research and
development remains costly and time consuming. The Drug Manufacturers
- Other industry has seen the above updates lately. And members can
today access complimentary reports for two companies, Teva
Pharmaceutical Industries Limited (NYSE: TEVA) and Allergan Inc.
(NYSE: AGN), serving this industry by following this link has brought together some of the best financial
and technical minds from around the biggest economies globally so
that you can have an array of free stock research and reporting. As
the global economy continues to experience colossal strain and
unprecedented actions are been taken by governments and the private
sectors to survive and boost the dwindling worldwide economic growth,
our researchers give you insight of how big players in different key
sectors and industries of the American exchanges are faring. Sign up
now for your free membership at  
On the legal side of things, battles over patent infringement cases
have led some companies higher while others have been dealt major
setbacks. Settlement agreements have been popular, though the
ultimate problem of loss of exclusivity is still a concern. Teva
Pharmaceutical Industries Limited financial analysis available by
signing up for free at  
To counter some of the aforementioned headwinds, several companies in
the industry have been expanding their operations abroad. Europe and
Asia have been popular expansion destinations, though Latin America
is also gaining in popularity. A number of companies have entered
into strategic alliances with foreign companies that are already
established abroad, which should make it easier for them to grow
moving forward. posted
 financial analysis on Allergan
Inc. today, members can access it at  
Getting the necessary approvals for their products is another story
though, and drug manufacturers that are able to team-up with foreign
businesses while also getting their products to market could be best
About Street-Wire:
 Street-Wire aims to satisfy our new members with
timely knowledge and to provide veteran traders with innovative and
cognitive content when it comes to investing. We believe learning is
a two-way channel, and we learn from our members as much as we
provide them with what they need to make sense of the markets. We
strive to introduce investors to new analytical viewpoint before the
market becomes aware of them.  
Read our Disclaimer  
Contact Person:
Anthony K. Merchant
Communications Executive 
Press spacebar to pause and continue. Press esc to stop.